BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines weighted-Average Diluted ADSs Outstanding (M ADSs) (M)
Form 10-Q / 10-K Net Loss/Income Per Share Note (XBRL)
Latest, Q2 2026
116
Period ended Jun 30, 2026
Change on a year earlier
+2.9%
113 in Q2 2025
History
20 quarters
Since Q1 2020
Sources
17
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted-Average Diluted ADSs Outstanding (M ADSs) (M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 116 | +2.9% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 116 | +4.1% | Form 10-Q (filed 2026-05-06) ↗ |
| Q3 2025 | Sep 30, 2025 | 115 | +8.1% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 113 | +7.5% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 111 | +6.6% | Form 10-Q (filed 2026-05-06) ↗ |
| Q3 2024 | Sep 30, 2024 | 106 | -1.0% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 105 | +0.1% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2024 | Mar 31, 2024 | 104 | +0.1% | Form 10-Q (filed 2025-05-07) ↗ |
| Q3 2023 | Sep 30, 2023 | 107 | +3.4% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2023 | Jun 30, 2023 | 105 | +1.8% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 104 | +1.7% | Form 10-Q (filed 2024-05-08) ↗ |
| Q3 2022 | Sep 30, 2022 | 103 | +11.5% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 103 | +11.9% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 102 | +5.9% | Form 10-Q (filed 2023-05-04) ↗ |
| Q3 2021 | Sep 30, 2021 | 92.8 | +5.0% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jun 30, 2021 | 91.9 | +18.2% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2021 | Mar 31, 2021 | 96.7 | +25.1% | Form 10-Q (filed 2022-05-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 88.4 | – | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 77.7 | – | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 77.3 | – | Form 10-Q (filed 2021-05-06) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Weighted-Average Diluted ADSs Outstanding (M ADSs) (M), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/wavg_ads_diluted
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.